Front Row Advisors’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
Other funds holding XRAY
GIM
VAM
Front Row Advisors's XRAY Position: Q3 2019 in Review
Front Row Advisors sold out of Dentsply Sirona (XRAY) in Q3 2019, closing a stake of 73 shares — an estimated $4K sold.
Front Row Advisors first reported a position in XRAY in Q2 2018 and held it in 5 quarters. The position peaked at $4K in Q2 2019. 532 funds tracked by Wall St. Rank hold XRAY as of Q3 2019.
- Front Row Advisors reported no remaining Dentsply Sirona position as of Q3 2019 after selling out during the quarter.
- Front Row Advisors sold 73 Dentsply Sirona shares in Q3 2019, an estimated $4K.
- Front Row Advisors first reported a position in Dentsply Sirona in Q2 2018 and held it in 5 quarters.
- Front Row Advisors's Dentsply Sirona position peaked at $4K in Q2 2019.
- 532 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2019.
Based on Front Row Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.